M&As this week: Asahi Glass, Allergan
Asahi Glass has acquired Biomeva from Biomeva Holding to expand its business.
Asahi Glass has acquired Biomeva from Biomeva Holding to expand its business.
The acquirer is a glass company, while the target company is a contract manufacturing business that manufactures and distributes biologics, APIs and therapeutic proteins.
Allergan has acquired all assets of RetroSense Therapeutics LLC to expand its ongoing development programmes.
According to the agreement, RetroSense will receive an upfront payment of $60m, as well as an additional regulatory and commercialisation milestone payments for its proprietary gene therapy RST-100 from Allergan.
Image: Allergan Plc has acquired all the assets of RetroSense Therapeutics LLC. Photo: Courtesy of Coolcaesar at the English language Wikipedia.